Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (571-580 of 1,095) with videos related to

Pageof 110
Sort By:
Journal of Hepatology|November 10, 2012
Clinical management of drug-drug interactions in HCV therapy: challenges and solutionsDavid Burger, David Back, Peter Buggisch, et al.
Journal of Viral Hepatitis|March 29, 2014
Development and evaluation of a baseline-event-anticipation score for hepatitis deltaB Calle Serrano, A Großhennig, M Homs, et al.
BMJ Open|December 23, 2022
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of BarcelonaAna Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, et al.
Plos One|December 30, 2015
Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B VirusAndrea Caballero, Josep Gregori, Maria Homs, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 3, 2015
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulinM Buti, D Tabernero, A Mas, et al.
Frontiers in Oncology|April 1, 2025
Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection: a case reportIlaria Gandolfini, Martina Manini, Giuseppe Daniele Benigno, et al.
Immunotherapy|July 17, 2018
Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumabMelissa Bersanelli, Letizia Gnetti, Cinzia Azzoni, et al.
BMJ Open|August 21, 2023
Implementation of the HepC<i>link</i> test-and-treat community strategy targeting Pakistani migrants with hepatitis C living in Catalonia (Spain) compared with the current practice of the Catalan health system: budget impact analysisJuliana Reyes-Urueña, Francisco Costell-González, Laia Egea-Cortés, et al.
Journal of Viral Hepatitis|May 18, 2021
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and CErika Duffell, Helena Cortez-Pinto, Marieta Simonova, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
Pageof 110

Showing results (571-580 of 1,095) with videos related to

Sort By:
Pageof 110
Journal of Hepatology|November 10, 2012
Clinical management of drug-drug interactions in HCV therapy: challenges and solutionsDavid Burger, David Back, Peter Buggisch, et al.
Journal of Viral Hepatitis|March 29, 2014
Development and evaluation of a baseline-event-anticipation score for hepatitis deltaB Calle Serrano, A Großhennig, M Homs, et al.
BMJ Open|December 23, 2022
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of BarcelonaAna Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, et al.
Plos One|December 30, 2015
Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B VirusAndrea Caballero, Josep Gregori, Maria Homs, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 3, 2015
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulinM Buti, D Tabernero, A Mas, et al.
Frontiers in Oncology|April 1, 2025
Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection: a case reportIlaria Gandolfini, Martina Manini, Giuseppe Daniele Benigno, et al.
Immunotherapy|July 17, 2018
Loss of heterozygosity of key tumor suppressor genes in advanced renal cancer patients treated with nivolumabMelissa Bersanelli, Letizia Gnetti, Cinzia Azzoni, et al.
BMJ Open|August 21, 2023
Implementation of the HepC<i>link</i> test-and-treat community strategy targeting Pakistani migrants with hepatitis C living in Catalonia (Spain) compared with the current practice of the Catalan health system: budget impact analysisJuliana Reyes-Urueña, Francisco Costell-González, Laia Egea-Cortés, et al.
Journal of Viral Hepatitis|May 18, 2021
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and CErika Duffell, Helena Cortez-Pinto, Marieta Simonova, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
Pageof 110